Changing nature of conventional therapy in chronic myelogenous leukemia

Saved in:
Bibliographic Details
Main Authors: Hehlmann, Rüdiger (Author) , Hochhaus, Andreas (Author)
Format: Chapter/Article
Language:English
Published: 1999
In: Medical management of chronic myelogenous leukemia
Year: 1999, Pages: 113-139
Online Access: Get full text
Author Notes:Rüdiger Hehlmann and Andreas Hochhaus

MARC

LEADER 00000caa a22000002c 4500
001 1804113328
003 DE-627
005 20220820190216.0
007 tu
008 220523s1999 xx ||||| 00| ||eng c
035 |a (DE-627)1804113328 
035 |a (DE-599)KXP1804113328 
035 |a (OCoLC)1341460274 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
245 1 0 |a Changing nature of conventional therapy in chronic myelogenous leukemia  |c Rüdiger Hehlmann and Andreas Hochhaus 
264 1 |c 1999 
300 |a 27 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a Hochhaus, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1107039339  |0 (DE-627)863321976  |0 (DE-576)474976130  |4 aut 
773 0 8 |i Enthalten in  |t Medical management of chronic myelogenous leukemia  |d New York [u.a.] : Dekker, 1999  |g (1999), Seite 113-139  |h XI, 442 S  |w (DE-627)248271520  |w (DE-576)9248271529  |z 0824799011  |7 nnam  |a Changing nature of conventional therapy in chronic myelogenous leukemia 
773 1 8 |g year:1999  |g pages:113-139  |g extent:27  |a Changing nature of conventional therapy in chronic myelogenous leukemia 
951 |a AR 
992 |a 20220523 
993 |a BookComponentPart 
994 |a 1999 
998 |g 1107039339  |a Hochhaus, Andreas  |m 1107039339:Hochhaus, Andreas  |d 60000  |d 61200  |e 60000PH1107039339  |e 61200PH1107039339  |k 0/60000/  |k 1/60000/61200/  |p 2  |y j 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |d 61200  |e 60000PH1037003489  |e 61200PH1037003489  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j 
999 |a KXP-PPN1804113328  |e 4138242910 
BIB |a Y 
JSO |a {"id":{"eki":["1804113328"]},"relHost":[{"language":["eng"],"part":{"extent":"27","text":"(1999), Seite 113-139","pages":"113-139","year":"1999"},"person":[{"family":"Talpaz","display":"Talpaz, Moshe","role":"edt","given":"Moshe"},{"role":"edt","given":"Hagop","display":"Kantarjian, Hagop","family":"Kantarjian"}],"recId":"248271520","relMultPart":[{"type":{"bibl":"serial"},"disp":"Basic and clinical oncology","title":[{"title_sort":"Basic and clinical oncology","title":"Basic and clinical oncology"}],"pubHistory":["1.1993 -"],"origin":[{"dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisher":"Dekker","publisherPlace":"New York, NY [u.a.]"}],"dispAlt":"Basic and clinical oncology","id":{"zdb":["2391798-2"],"eki":["546561403"]},"part":{"number":["16"],"number_sort":["16"]},"language":["eng"],"recId":"546561403"}],"physDesc":[{"noteIll":"graph. Darst","extent":"XI, 442 S"}],"name":{"displayForm":["ed. by Moshe Talpaz; Hagop M. Kantarjian"]},"id":{"eki":["248271520"],"isbn":["0824799011"]},"title":[{"title":"Medical management of chronic myelogenous leukemia","title_sort":"Medical management of chronic myelogenous leukemia"}],"note":["Includes bibliographical references and index"],"origin":[{"publisherPlace":"New York [u.a.]","dateIssuedDisp":"1999","dateIssuedKey":"1999","publisher":"Dekker"}],"disp":"Changing nature of conventional therapy in chronic myelogenous leukemiaMedical management of chronic myelogenous leukemia","type":{"bibl":"edited-book"}}],"recId":"1804113328","language":["eng"],"name":{"displayForm":["Rüdiger Hehlmann and Andreas Hochhaus"]},"physDesc":[{"extent":"27 S."}],"type":{"bibl":"chapter"},"person":[{"given":"Rüdiger","role":"aut","family":"Hehlmann","display":"Hehlmann, Rüdiger"},{"given":"Andreas","role":"aut","display":"Hochhaus, Andreas","family":"Hochhaus"}],"origin":[{"dateIssuedDisp":"1999","dateIssuedKey":"1999"}],"title":[{"title_sort":"Changing nature of conventional therapy in chronic myelogenous leukemia","title":"Changing nature of conventional therapy in chronic myelogenous leukemia"}]} 
SRT |a HEHLMANNRUCHANGINGNA1999